Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 8 at 2:00 PM EDT

Register Free →

AJ12--Special Notice | Intent to Sole Source | Biostatistics Support for Prostate Cancer Analysis for Treatment Choice (PATCH) Clinical Trials Consortium

Active
36C24526Q0624Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Veterans Health Administration, Network Contracting Office 5, intends to award a sole source contract to CANCER RESEARCH & BIOSTATISTICS for biostatistics support services related to the Prostate Cancer Analysis for Treatment Choice (PATCH) Clinical Trials Consortium. The vendor will deliver expert analytical and consulting services to all member institutions of the Precision Oncology Program for Cancer of the Prostate and select sites within the Lung Precision Oncology Program. The work is essential for advancing clinical trial data interpretation and treatment optimization in prostate cancer research within the VA healthcare system. The contract will be issued under FAR Subpart 13.106-1(b), reflecting the government’s determination that only this vendor possesses the unique expertise required to fulfill the requirement. This notice is not a solicitation for competitive bids, but any capable responsible source may submit a capability statement, proposal, or quotation prior to the deadline of July 12, 2026, at 12:00 PM Eastern Time. The government retains full discretion to determine whether to proceed with sole source award based on any submissions received. The action is categorized under NAICS code 541714 for scientific research and development services, and all communications must be directed to Contracting Officer Ethan Mauzy at the Department of Veterans Affairs office in Linthicum, Maryland. The solicitation number is 36C24526Q0624, and details are accessible via the SAM.gov website.

General Info

Sole source contract to CANCER RESEARCH & BIOSTATISTICS for prostate cancer biostatistics support under VA’s Precision Oncology Program.

Agency

Department Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)View Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(1)

36C24526Q0624 Special Notice Intent to Sole Source Biostatistics Support PATCH Clinical Trials

DOCXspecial-notice

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
Posted

special-notice

Amendment 0

Contract was updated

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)
Contacts1 person available
OfficeLINTHICUM, MD, 21090, USA
Organization / Agency
Department Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)
View Agency Profile
Office AddressLINTHICUM, MD, 21090, USA
Contacts
Ethan MauzyContracting Officer

Full Description

Show more
Pursuant to FAR Subpart 13.106-1(b), Veterans Health Administration (VHA), Network Contracting Office 5 intends to solicit from a single source for the purchase of Biostatistics Support for Prostate Cancer Analysis for Treatment Choice (PATCH) Clinical Trials Consortium services from CANCER RESEARCH & BIOSTATISTICS (SAM UEI: PNQDLXQ6RGD5). Under the contemplated contract, the vendor will provide will provide expert consultation and analytics support to all member institutions of Precision Oncology Program for Cancer of the Prostate (POPCaP) and selected sites within Lung Precision Oncology Program (LPOP).
This notice of intent to conduct a sole source acquisition is not a request for competitive proposals. However, any responsible source who believes it is capable of performing the requirement may submit a capability statement, proposal, or quotation, which shall be considered by the agency, only if received by the closing date and time of this notice. A determination not to compete the proposed requirement based upon the responses to this notice is solely within the discretion of the Government.

Similar Contracts

NAICS: 541714
New
Federal
Exosome Purification, Exosomal RNA Purification, and Small RNA-Sequencing ServicesThe National Institutes of Health, in collaboration with the National Institute on Alcohol Abuse and Alcoholism and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, seeks specialized laboratory services to support the POTS clinical research study conducted at NIH in Bethesda, Maryland. The contract requires a qualified provider to process 31 irreplaceable plasma specimens from human participants, performing integrated exosome isolation, exosomal RNA purification, and small RNA-sequencing using Illumina platforms. These tasks must be completed with strict adherence to sample integrity and chain of custody protocols, as the requiring laboratory lacks the validated capacity or bandwidth to perform these procedures in-house within the required timeframe. Each specimen, consisting of 0.5 mL of plasma, must be processed to yield intact exosomes split into multiple aliquots, with exosomal RNA extracted and_QUALITY controlled, and a portion used for downstream sequencing. The contractor is responsible for supplying all personnel, equipment, reagents, and materials necessary to complete the work. The provider must prepare libraries, sequence all 31 samples on the Illumina platform with a target of approximately 20 million raw reads per sample at 1x51 bp, and deliver sequencing data to the government via both physical hard drive and digital download. Basic bioinformatics processing, including read trimming, filtering, and mapping, is also required to ensure analysis-ready outputs. All specimens and resulting materials must be returned to the NIH in accordance with prescribed protocols, maintaining proper documentation and tracking throughout the entire workflow. The solicitation, numbered 75N98026Q00707, is open for response until July 7, 2026, under NAICS code 541714, with no set-aside requirements, and point of contact for inquiries is John Burton at NIH.
National Institutes Of Health Olao

POSTED

3 days ago

DEADLINE

in 9 days
View Details